Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data
Main Authors: | Levin, P, Wei, W, Miao, R, Ye, F, Xie, L, Baser, O, Gill, J |
---|---|
Format: | Online |
Language: | English |
Published: |
Blackwell Publishing Ltd
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383352/ |
Similar Items
-
Much Ado About Nothing? A Real-World Study of Patients with Type 2 Diabetes Switching Basal Insulin Analogs
by: Wei, Wenhui, et al.
Published: (2014) -
Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine
by: Miao, Raymond, et al.
Published: (2013) -
Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study
by: Wang, Li, et al.
Published: (2013) -
The metabolic and mitogenic properties of basal insulin analogues
by: Tennagels, Norbert, et al.
Published: (2013) -
Review of Insulin and its Analogues in Diabetes Mellitus
by: Mane, Krishnappa, et al.
Published: (2012)